Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling.
about
PTPN14 is required for the density-dependent control of YAP1The serologically defined colon cancer antigen-3 interacts with the protein tyrosine phosphatase PTPN13 and is involved in the regulation of cytokinesisIdentification of PTPN23 as a novel regulator of cell invasion in mammary epithelial cells from a loss-of-function screen of the 'PTP-ome'Receptor protein tyrosine phosphatase-receptor tyrosine kinase substrate screen identifies EphA2 as a target for LAR in cell migrationThe catalytic region and PEST domain of PTPN18 distinctly regulate the HER2 phosphorylation and ubiquitination barcodesN-acetylcysteine negatively regulates Notch3 and its malignant signalingHepatitis C virus induced miR200c down modulates FAP-1, a negative regulator of Src signaling and promotes hepatic fibrosisProtein-tyrosine phosphatase PTPN9 negatively regulates ErbB2 and epidermal growth factor receptor signaling in breast cancer cells.miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in miceProtein tyrosine phosphatases as potential therapeutic targets.PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinaseExpression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformationSildenafil (Viagra) sensitizes prostate cancer cells to doxorubicin-mediated apoptosis through CD95Valosin containing protein (VCP/p97) is a novel substrate for the protein tyrosine phosphatase PTPL1.Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascitesPTPL1: a large phosphatase with a split personality.Expression of the putative tumor suppressor gene PTPN13/PTPL1 is an independent prognostic marker for overall survival in breast cancer.Cell polarity factor Par3 binds SPTLC1 and modulates monocyte serine palmitoyltransferase activity and chemotaxis.Autophagy variation within a cell population determines cell fate through selective degradation of Fap-1.PTPRO represses ERBB2-driven breast oncogenesis by dephosphorylation and endosomal internalization of ERBB2PTPN13/PTPL1: an important regulator of tumor aggressiveness.Genetic alterations of protein tyrosine phosphatases in human cancers.Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family.Tumour-suppressive role of PTPN13 in hepatocellular carcinoma and its clinical significance.Impaired PTPN13 phosphatase activity in spontaneous or HPV-induced squamous cell carcinomas potentiates oncogene signaling through the MAP kinase pathwaySilencing of ErbB3/ErbB2 signaling by immunoglobulin-like Necl-2.Feedback control of ErbB2 via ERK-mediated phosphorylation of a conserved threonine in the juxtamembrane domain.Proteasome inhibitors prevent bi-directional HER2/estrogen-receptor cross-talk leading to cell death in endocrine and lapatinib-resistant HER2+/ER+ breast cancer cells.Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer.Suppression of protein tyrosine phosphatase N23 predisposes to breast tumorigenesis via activation of FYN kinase.Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus-associated oropharyngeal squamous cell cancer.Cadm3 (Necl-1) interferes with the activation of the PI3 kinase/Akt signaling cascade and inhibits Schwann cell myelination in vitro.
P2860
Q24297998-DAC06C87-552B-4731-B877-54E8CA97924DQ24302108-89F2ADD7-A887-475B-A171-0AB6E4577A19Q24309666-18BE2019-8281-4523-8B13-6D54C2D93A74Q24312704-CDF7B244-8856-4528-95AE-214F662D0313Q28118816-5E864E83-D3B4-4DCA-B68C-A91D04A4A59FQ28391353-B6A7E23D-45FA-4DB5-94E1-F646AA32D2F3Q31126487-A36E7CBA-ABC4-47CF-833E-D16DF88FBAA4Q33832583-DC0837BD-D330-47BC-9718-03385A2CAB3BQ33996050-974897E8-4DCF-4DEF-93DD-884841F99D80Q34146018-2B2FB4CF-9A10-4D24-B724-A5EE73B8EA68Q34295063-F1A21E61-E863-42FE-9F00-307917521FFFQ35094072-8C657A97-7DE4-411B-A475-0E1EE512D4EDQ36277279-E7E630BA-3202-4478-8157-9FD8D978CEF4Q36782452-01DAA79A-D59C-402A-AF38-8268A38582D5Q36802612-31C9FF73-491C-4694-9F20-CC5B0ADEB11EQ36946716-899CCB5B-8961-43AA-9ECF-FE3FED8919ADQ37081432-E63EF1B2-EE7A-4A05-9E64-5A2B25A8D22CQ37340004-93B2493B-1A65-4D7F-BF04-C9A4AAA2CF68Q37375669-5F3A6FB4-C752-4DB5-8084-AD9E0D9F428BQ37420801-CFEB5F16-4DC8-4522-A420-5A2A405420AEQ37609203-8ADEA5C1-417B-4644-80CD-82E376426151Q37828546-7CD4844E-0BBE-46FB-8E75-8FF62E965661Q38255066-A3854B65-A0EA-4479-ADDC-22E4B319E3BAQ38444703-E9351F01-3866-4DB0-B412-FBCE7DDE5456Q38800302-61255555-9496-490E-872D-58B0B62522F5Q39802740-1AB29544-EF89-486B-BC32-EFE9953B4EB0Q39832060-06C45866-6262-4605-B41D-41BFB5A1F648Q41729710-6FF50B26-ABD1-4955-9F57-62946D45A118Q42563273-0809428F-1962-4A9E-A754-91942736B4FDQ46228471-505D0E38-FFB5-4544-81CB-E5CC5B1F474AQ47608480-4DF5BD16-7D5A-4836-91C6-4FAC4F3E1A35Q47722276-8AF1BF31-8857-4564-A7A6-ED373189F7F2Q51474265-8D26B0DC-0E6E-42AE-A3BF-4B108912DAE8
P2860
Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling.
@ast
Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling.
@en
Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling.
@nl
type
label
Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling.
@ast
Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling.
@en
Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling.
@nl
prefLabel
Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling.
@ast
Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling.
@en
Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling.
@nl
P2093
P2860
P356
P1433
P1476
Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling.
@en
P2093
Yates JR 3rd
P2860
P2888
P304
P356
10.1038/SJ.ONC.1210922
P407
P577
2007-11-05T00:00:00Z
P5875
P6179
1040609008